title: Transcriptional silencing of the Dickkopfs-3 (Dkk-3) gene by CpG hypermethylation in acute lymphoblastic leukaemia.
abstract: DKK-3: is a newly characterised mortalisation-related gene and an antagonist of the Wnt oncogenic signalling pathway whose expression is decreased in a variety of cancer cell lines, suggesting that the Dkk-3 gene, located at chromosome 11p15.1, functions as a tumour suppressor gene. Although 11p15 is a 'hot spot' for methylation in acute lymphoblastic leukaemia (ALL), the role of Dkk-3 abnormalities has never been evaluated in this disease. We analysed CpG island methylation of the Dkk-3 promoter in six ALL cell lines and 183 ALL patients. We observed Dkk-3 hypermethylation in all cell lines and in cells from 33% (60/183) of ALL patients. Moreover, Dkk-3 methylation was associated with decreased Dkk-3 mRNA expression and this expression was restored after exposure to the demethylating agent 5-AzaC. Clinical features did not differ between hypermethylated and unmethylated patients. Estimated disease-free survival (DFS) and overall survival at 10 and 11 years, respectively, were 49.8 and 45.6% for normal patients and 10.5 and 15.1% for hypermethylated patients (P=0.001 and 0.09). Multivariate analysis demonstrated that Dkk-3 methylation was an independent prognostic factor predicting DFS (P=0.0009). Our data suggest that Dkk-3 methylation occurs at an early stage in ALL pathogenesis and probably influences the clinical behaviour of the disease.
authors.affiliation: 1Hematology Department, Molecular Biology Unit, Reina Sofia Hospital, 14004 Cordoba, Spain. peperosa@teleline.es
authors.forename: J
authors.initials: J
authors.lastname: Roman-Gomez
authors.forename: A
authors.initials: A
authors.lastname: Jimenez-Velasco
authors.forename: X
authors.initials: X
authors.lastname: Agirre
authors.forename: J A
authors.initials: JA
authors.lastname: Castillejo
authors.forename: G
authors.initials: G
authors.lastname: Navarro
authors.forename: M
authors.initials: M
authors.lastname: Barrios
authors.forename: E J
authors.initials: EJ
authors.lastname: Andreu
authors.forename: F
authors.initials: F
authors.lastname: Prosper
authors.forename: A
authors.initials: A
authors.lastname: Heiniger
authors.forename: A
authors.initials: A
authors.lastname: Torres
mesh_terms: D048868:Adaptor Proteins, Signal Transducing; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002471:Cell Transformation, Neoplastic; D018925:Chemokines; D002648:Child; D002675:Child, Preschool; D002880:Chromosomes, Human, Pair 11 / Q000235:genetics*; D018899:CpG Islands; D019175:DNA Methylation; D004273:DNA, Neoplasm / Q000378:metabolism; D005260:Female; D020868:Gene Silencing; D006801:Humans; D007223:Infant; D036341:Intercellular Signaling Peptides and Proteins; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics*; D011379:Prognosis; D011401:Promoter Regions, Genetic; D014176:Protein Biosynthesis; D011506:Proteins / Q000235:genetics*; D016019:Survival Analysis; D014158:Transcription, Genetic; D014407:Tumor Cells, Cultured
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D018925:Chemokines; C498624:DKK3 protein, human; D004273:DNA, Neoplasm; D036341:Intercellular Signaling Peptides and Proteins; D011506:Proteins